Company / Revenue per Share
Progyny Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.11
FY2025
5-year range
$4.99 / $15.11
FY2021-FY2025
Trend
+24.7%
vs FY2024
Sector context
#97 of 147
Health Care
What the data says
At $15.11, Progyny's revenue per share ranks #97 of 147 in the Health Care sector. Revenue per Share has increased for 5 consecutive years, from $3.48 in FY2020 to $15.11 in FY2025.
Based on SEC 10-K filings.
15.11 in FY2025 with a 5-year CAGR of +34.1%.
Improved from $11.67 to $15.11 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +20.5%
- 5-Year CAGR
- +34.1%
- 10-Year CAGR
- -
Sector benchmark
#97 of 147 in Health CareTop 66% of 147This company $15.11 Sector average $127.83
▼
-88.2% below sector average
Key checks
Key Insights
- Progyny's revenue per share has grown for 5 consecutive years.
- In FY2025, revenue per share increased 24.7% year-over-year.
- Ranks #97 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.11 | +24.7% |
| FY2024 | $12.11 | +3.8% |
| FY2023 | $11.67 | +35.1% |
| FY2022 | $8.64 | +73.2% |
| FY2021 | $4.99 | +43.3% |
| FY2020 | $3.48 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026